Currently there is no description available for Penny Ward.
“The availability of a well-tolerated, effective oral antiviral [molnupiravir] will be particularly useful in supplementing vaccination as a means to reduce the proportion of patients needing hospital care. It is greatly hoped that the antiviral taskforce has, like the vaccines taskforce, preordered courses of this medication so that the UK can, at last, properly manage this condition by treating vaccine breakthrough disease and relieve pressure on the NHS during the forthcoming winter.”
01 Oct 2021
4
4
Read More
